Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment
- 18 July 2008
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 8 (1), 70-77
- https://doi.org/10.1111/j.1365-2893.2001.00268.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Factors predictive of a beneficial response to therapy of hepatitis CHepatology, 1997
- Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trialsHepatology, 1997
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATIONTransplantation, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis CHepatology, 1995
- Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose studyGastroenterology, 1994
- Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.Gut, 1993
- Interferon–α in Acute Posttransfusion Hepatitis C:. A Randomized, Controlled TrialHepatology, 1992
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989